| Name | Title | Contact Details |
|---|
Our approach consists of four primary factors: 1. Provide a personalized experience with every customer interaction. 2. Offer products with inherent value that address unique customer needs. 3. Locally owned and operated. 4. Loans deployed to assist local businesses and residents. Member FDIC. Equal Housing Lender.
Landscape Forms is the industrys premier global brand of outdoor furniture, LED lighting and accessories. Since its founding in 1969 Landscape Forms has earned a reputation for excellent design, high quality products and exceptional service. The Landscape Forms U.S. headquarters and manufacturing facility is located in Kalamazoo, Michigan with sales representatives throughout North America, the United Kingdom, Southern Europe, the United Arab Emirates and Asia. Landscape Forms collaborates with renowned industrial designers and consultancies, landscape architects, and architects to design and develop integrated collections of products that address emerging needs and help create a sense of place. The company has an installed base of products around the world. Clients include municipalities, transit centers, corporate, college and health care campuses; and familiar brand leaders such as Boeing, Cisco Systems, Disney, Sprint, American Airlines, Herman Miller and Nike. Landscape Forms was recently named by the Wall Street Journal as one of the Top 15 Small Workplaces in the US.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Alliance Animal Health is a multi-site business partner to veterinarians across the US. Alliance Animal Health allows veterinarians to continue to practice medicine independently while providing resources and assistance in business operations. Veterinarians retain all the benefits of being an independent practice, but gain the additional advantages associated with becoming part of a larger organization. These include access to professional marketing, inventory management expertise, purchasing power, recruiting support, collaborative synergies, and financial resources. Our network of general practice and emergency hospitals is as individual as you, and we like it that way! Our network of highly skilled partners and associate veterinarians work hard to deliver the quality of personalized care and attention that our profession deserves. We pride ourselves on maintaining a culture of open communication and collaboration to remain innovative and cutting edge in todays veterinary environment without disrupting the medical autonomy of our qualified veterinarians.